Little evidence new cancer drugs improve survival

(Reuters Health) – There’s not much evidence to show that most new cancer drugs approved in Europe in recent years can help patients live longer or improve their quality of life, a recent study suggests.

This post was syndicated from Reuters: Health News. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply